At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Follow-up schedule: pre-operative baseline up to 24-months post-procedure (device)
- How long the study runs
- Study runs about 96 months (dates as stated)
- About the drug or intervention
- Follow-up schedule: pre-operative baseline up to 24-months post-procedure — device: Follow-up assessments will be required (therefore interventional) from pre-operative baseline to 24 months post index surgery
- Patient visit burden
- Not specified by the sponsor
In plain English
This study, run by Medtronic Spinal and Biologics, looks at people treated with eligible Medtronic Cranial and Spinal Technology devices for conditions affecting the spine, such as spinal deformity, degenerative disorder, fusion failure, trauma or tumour. It is a post-market study, meaning it collects information after the devices are already in normal use.
Who can take part
- You give written informed consent, following your hospital's and local rules.
- You are due to be treated with an eligible Medtronic Cranial and Spinal Technology device, on its own or with others, for a condition of the skull or spine.
- You are at least 18 years old, or the minimum legal age where you live.
- You agree to complete all the required study assessments.
Who may not be able to
- You are taking part, or plan to take part, in another trial of a drug, device or biological product that could affect this study's results, in the researcher's view.
- You cannot, or are not expected to be able to, attend all the required follow-up visits.
- You meet any exclusion set by local law.
- You are considered vulnerable at the time of giving consent.
What taking part involves
- • Not stated — ask the trial team.
Time commitment: Not stated — ask the trial team about number of visits, how long the study lasts, and what taking part involves.
Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.
- Type of study
- Testing a treatment
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 1,000
- Started
- 2023-05-01
- Last checked
- 2026-08
Plain English Summary
What is this study?
- • Testing a new treatment for spinal deformity
- • NA - 1,000 participants
- • The purpose of this clinical study is to collect performance and safety data for post-market Medtronic devices indicated for cranial and/or spinal indication(s)
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with spinal deformity
Where?
- • London - Kings College Hospital NHS Foundation Trust
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The purpose of this clinical study is to collect performance and safety data for post-market Medtronic devices indicated for cranial and/or spinal indication(s). Subjects are enrolled and followed postoperatively to 24 months. The Ailliance clinical study is intended to collect data congruous with routine clinical care practices.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
Treatment history
Treatments you must have had:
- ✓ by local regulations
- ✓ assessments per the Schedule of Events
What the study is looking for
- ✓Subject provides written agreement to take part per institution and/or geographical requirements.
- ✓Subject is at least 18 years of age or minimum legal age as required by local regulations.
- ✓Subject agrees to complete all required assessments per the Schedule of Events.
Who cannot take part
- ✗Subject who is, or is expected to be, inaccessible for all required follow-up visits.
- ✗Subject with exclusion criteria required by local law.
- ✗Subject is considered vulnerable at the time of obtaining consent.
See the full criteria
Where Is This Study? (1 UK site)
Kings College Hospital NHS Foundation Trust
London SE5 9RS, United Kingdom
How to Get in Touch
Lauren Oien
Sponsor contactCONTACT
Erwan Diarra
Sponsor contactCONTACT